Sindhu Johnson
@SindhuJohnson5
Followers
1K
Following
3K
Media
101
Statuses
671
Rheumatologist, Clinical Epidemiologist, Director: Clinical Epidemiology Program, @UofT_DoM @uoftmedicine @ihpmeuoft @SinaiHealth @SchroederInst #Scleroderma
Joined February 2021
A wonderful evening at #Irth with many of my former trainees (the Jo Squad) aka the inaugural Saudi Scleroderma Society meeting. Many thanks @AboabatAos @WaleedHafiz786 @rawadnori @nezarbakhsh @KholoudH5 @Huda_Alfaris @HanaRheum @ssrsa_org
0
3
28
🦠 “Understanding the connection between the gut-lung axis in [systemic sclerosis-associated interstitial lung disease] may improve our knowledge of the pathogenesis of this condition,” said Kristofer Andréasson, MD, PhD, from @LundUniversity. Read more: https://t.co/GJllQF1pSx
healio.com
Patients with interstitial lung disease in systemic sclerosis demonstrate distinct intestinal microbiota that may help identify pathogenesis and targeted treatments, according to data published in...
0
1
1
Have you heard of Raynaud’s Warriors? Share your story on our Tell Us About You Form for a chance to be published. #RaynaudsWarriors #ShareYourStory 💪📝 https://t.co/0yQ1eZiMte
#raynaudsphenomenon,
0
1
4
SLE may be underrecognized in IPAF. Among 201 patients initially classified as IPAF, 26 met 2019 and/or SLICC criteria for SLE. 2019 criteria may be a more sensitive tool for detecting SLE among patients with ILD and autoimmune features. https://t.co/sZwj0HD9EZ
1
1
1
🌍Global collaboration to weight a new #lupus damage index. Thrilled to work with @fizyobrk @Lupusdoc @chriswincup @SarahKSilverman @cristianasieiro & others🇳🇬🇪🇬🇬🇧🇧🇷🇨🇦🇳🇿🇨🇳🇱🇰🇰🇪🇿🇦🇹🇷🇮🇹Thank you @ACRheum @LupusOrg for your support! 🙏🏽#ConjointAnalysis #Consensus
0
2
14
2) A multi-criteria decision-making exercise to define item weighting for the revised SDI was brilliantly facilitated by Dr Alison Hendry and @SindhuJohnson5. It’s been an inspiring and productive few days and the revised SDI is now one big step closer!💪🏻
0
1
2
🆕 Collaboration with @RheumNow 🔵 3-Part Series on #InterstitialLungDisease Part 3️⃣: Treatment of #ILD 💊 Medication Options for Rx of ILD 💉 🫁 How to Treat Different ILD Subtypes 🚶🏻♀️Holistic Approach to Management ❌🚬 #RheumTwitter #PulmTwitter #IPF #PulmX
0
35
109
🆕 ILD (Part III): clinical practice focus 🔬 Diagnostic challenges 🧑⚕️ Case-based learning 📈 Evidence & outcomes 🌍 Global perspectives ⬇️ Download & learn more: https://t.co/evDgNiVVH8 Created by @MithuRheum | For our Rheum to Breathe: ILD Campaign
1
20
49
Flu season is on its way. 🤒🤧😷Hot tip 🔥: @ACRheum guidelines recommend holding MTX after flu vaccine for 2 weeks if disease activity allows. #OntarioBestPracticesResearchInitiative. @MovahediMoh @BindeeKuriya
0
8
18
Join us Sept 23 @ 7PM ET for the next Rheum to Breathe Journal Club! We’ll dive into two pivotal ILD studies: 📄 FIBRONEER (Nerandomilast in PPF) – NEJM 2025 📄 RECITAL (Rituximab vs Cyclophosphamide in CTD-ILD) – Lancet Panelists: Dr. Toby Maher, Dr. Shervin Assassi Moderator:
0
3
10
IHPME's Dr. Zahi Touma discusses the work being done at the Toronto Lupus Program, specifically how cognitive impairment in lupus patients is identified. Read the full article: https://t.co/COBU2zOsyt
uhnfoundation.ca
Macenzie Rebelo Nineteen-year-old Macenzie Rebelo anxiously sat in the emergency room of her local hospital awaiting the results of a long-needed X-ray.
0
3
8
QD Clinic: Application of the ACR CHEST Guidelines to Two Cases Dr. Sindhu Johnson, Toronto, discusses two cases that where the application of the ACR CHEST guidelines for the screening, monitoring and treatment of SSc-ILD and Rapidly Progressive ILD are applied, as part of
0
7
13
🆕 Collaboration with @RheumNow 🔵 3-Part Series on #InterstitialLungDisease Part2️⃣: Diagnosis & Subtypes of #ILD 🫁 👩🏻⚕️ What to look for on Physical Exam 🧪 Serologic Testing & Diagnostic Workup 🫁 Differentiating ILD Subtypes on Imaging #RheumX #Pulmonology #MedTwitter #MedX
2
36
89
TNR: Future Treatment of ILD This Tuesday Night Rheumatology webinar reviewed ACR and EULAR guidelines on interstitial lung disease, with a focus on ‘where are we now and where are we going?’ in regards to treatment strategies and emerging therapies in ILD care.
0
5
15
🆕 Collaboration with @RheumNow 🔵 3-Part Series on #InterstitialLungDisease Part I: Introduction to #ILD 🫁 🔹Learn about different subtypes of ILD 🔹Signs/Symptoms of Initial Presentation 🔹What is the prevalence of ILD in various SARDs? #RheumTwitter #PulmTwitter #RheumX
2
31
71
📣September 📅 marks the ILD (pulmonary fibrosis) 🫁campaign @RheumNow! Catch a quick synopsis of the @ACR @CHEST ILD 🫁🩻💊 Guidelines. #RheumToBreathe
@SchroederInst @UofTRheum
@SclerodermaCAN @PFFORG @ActionPFcharity @wescoeforpf
https://t.co/MNykBnCSuv
rheumnow.com
Watch our 11-video series on ILD Treatment and Guidelines including videos on assessing ILD, guidelines caveats and concerns, and more.
0
2
2
🌐 ILD Treatment Guidelines – LIVE Webinar 📅 Sept 9 | ⏰ 7PM EST An expert panel reviews ACR & EULAR guidance and looks ahead at emerging therapies. Speakers: Drs. Sindhu Johnson, Anna-Maria Hoffmann-Vold, Scott Matson & Jack Cush, Moderator https://t.co/2F3sOjqHtr
#ILD
5
10
43
Congratulations @ihpmeuoft #ClinEpi student @Anudarizorigt on the publication of this beautifully written piece in the @NEJM from the #NarrativeMedicine course taught by @ADetsky. @UofT_dlsph
Sharing a personal essay honoring my father and the organ donors who gave us more precious time together. I hope it inspires more people to become donors, offers courage to those waiting, and peace to families who’ve given the ultimate gift of life. Read here:
2
2
12